Vladimir K. Bakalov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Vladimir K. Bakalov has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Carolyn A. Bondy
Section on Epigenetics & Development, Program on Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, 20892
4 shared publicationsLawrence M. Nelson
Program on Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, 20892
3 shared publicationsJames C. Reynolds
2 shared publicationsJeffrey Baron
2 shared publicationsJian Zhou
Section on Epigenetics & Development, Program on Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, 20892
2 shared publications- Anne Fogli
INSERM UMR384, Faculté de médecine, Clermont-Ferrand, France
1 shared publication
Latest Publications
- 1 June 2012
- Published by Elsevier in Journal of Autoimmunity
- Vol. 38 (4) , 315-321
Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency
- 1 June 2012
- Published by Elsevier in Journal of Autoimmunity
- Vol. 38 (4) , 315-321
Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency
- 1 June 2011
- Published by The Endocrine Society
- p. P2-166
Education, Employment, and Marriage for U.S. Adults with Turner Syndrome
Turner Syndrome (TS) affects ∼ 1/2500 live-born females. The diagnosis requires the complete or partial absence of the second sex chromosome, associated with short stature and early ovarian failure. There is little information on adjustment to adult life for women with TS. We surveyed the educational attainment, employment, and marital status of 240 women with TS, aged 25-67 (mean 40 years), participating in an NIH natural history study in 2001-2010. All subjects had a 50-cell karyotype demonstrating < 30% normal cells. Normative data for the US female population was obtained from the US Census Bureau (www.factfinder.census.gov). Education: 70% of our TS cohort had a baccelaureate degree or higher, compared to 26% of US women. In addition, 6% of our TS cohort had a professional degree in medicine, law, or research vs. 3% of the general population. Employment: 80% of our TS group was employed outside the home, compared to 70% of the US female population. The most common job categories reported by the TS population were Healthcare Practitioners and Technical Occupations (18%); Education, Training, and Library Occupations (15%); and Healthcare Support Services (12%) according to the Bureau of Labor and Statistics classification system, accounting for 9, 10, and 4.5% of employment for the general female population, respectively. Marriage: 48% of our TS group had married, vs. 78% of the general female population. Thirty-three women had children; 24 had adopted and 9 women had spontaneous or donor egg with IVF pregnancies. A multivariate analysis was used to determine contributions of current age, age at diagnosis, and adult height on education, employment, and marriage. For education level and employment status, none of these factors proved significant. However, we found that age was positively correlated (p=0.01), and height negatively correlated (p=0.028), with marriage rate. Women with TS participating in the NIH study achieved higher than average education levels and were employed at comparable rates, but were less likely to marry than the general female population. Nothing to Disclose: HNG, CJT, VKB, CAB
- 1 June 2011
- Published by The Endocrine Society
- p. P2-166
Education, Employment, and Marriage for U.S. Adults with Turner Syndrome
Turner Syndrome (TS) affects ∼ 1/2500 live-born females. The diagnosis requires the complete or partial absence of the second sex chromosome, associated with short stature and early ovarian failure. There is little information on adjustment to adult life for women with TS. We surveyed the educational attainment, employment, and marital status of 240 women with TS, aged 25-67 (mean 40 years), participating in an NIH natural history study in 2001-2010. All subjects had a 50-cell karyotype demonstrating < 30% normal cells. Normative data for the US female population was obtained from the US Census Bureau (www.factfinder.census.gov). Education: 70% of our TS cohort had a baccelaureate degree or higher, compared to 26% of US women. In addition, 6% of our TS cohort had a professional degree in medicine, law, or research vs. 3% of the general population. Employment: 80% of our TS group was employed outside the home, compared to 70% of the US female population. The most common job categories reported by the TS population were Healthcare Practitioners and Technical Occupations (18%); Education, Training, and Library Occupations (15%); and Healthcare Support Services (12%) according to the Bureau of Labor and Statistics classification system, accounting for 9, 10, and 4.5% of employment for the general female population, respectively. Marriage: 48% of our TS group had married, vs. 78% of the general female population. Thirty-three women had children; 24 had adopted and 9 women had spontaneous or donor egg with IVF pregnancies. A multivariate analysis was used to determine contributions of current age, age at diagnosis, and adult height on education, employment, and marriage. For education level and employment status, none of these factors proved significant. However, we found that age was positively correlated (p=0.01), and height negatively correlated (p=0.028), with marriage rate. Women with TS participating in the NIH study achieved higher than average education levels and were employed at comparable rates, but were less likely to marry than the general female population. Nothing to Disclose: HNG, CJT, VKB, CAB
- Open Access
- 1 September 2009
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 94 (9) , 3289-3296
X-Chromosome Gene Dosage and the Risk of Diabetes in Turner Syndrome
Background: Turner syndrome (TS) is caused by the absence or fragmentation of the second sex chromosome. An increased risk of diabetes mellitus (DM) has consistently been noted, but the specific phenotype and genetic etiology of this trait are unknown. Methods: In a prospective study, we examined the prevalence of DM in adult participants in an intramural National Institutes of Health (NIH) TS study. Results were analyzed with respect to karyotype, age, body mass index (BMI), and autoimmune indices. Insulin sensitivity and secretion were compared in age- and BMI-matched euglycemic women with TS and healthy female controls. We compared gene expression profiles in lymphocytes from differentially affected TS groups. Results: Type 2 DM was present in 56 of 224 (25%) of the women with TS; type 1 DM was found in only one woman (vs. 17.3%; P = 0.004). Euglycemic women with TS (n = 72; age, 33 ± 12 yr; BMI, 23 ± 3 kg/m2) had significantly higher glycemic and lower insulin responses to OGTT, with insulin sensitivity similar to controls. Gene expression profiles comparing 46,X,i(X)q vs. 45,X groups showed a significant increase in Xq transcripts and in potentially diabetogenic autosomal transcripts in the isoXq group. Conclusion: Type 2 DM associated with deficient insulin release is significantly increased among women with monosomy for the X-chromosome but is increased even more among women with monosomy for Xp coupled with trisomy for Xq. These data suggest that haploinsufficiency for unknown Xp genes increases risk for DM and that excess dosage of Xq genes compounds the risk. In Turner syndrome, haploinsufficiency for unknown Xp chromosome genes increases the risk for diabetes, and excess dosage of Xq genes compounds that risk.
- 1 September 2009
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 94 (9) , 3289-3296
Open AccessX-Chromosome Gene Dosage and the Risk of Diabetes in Turner Syndrome
Background: Turner syndrome (TS) is caused by the absence or fragmentation of the second sex chromosome. An increased risk of diabetes mellitus (DM) has consistently been noted, but the specific phenotype and genetic etiology of this trait are unknown. Methods: In a prospective study, we examined the prevalence of DM in adult participants in an intramural National Institutes of Health (NIH) TS study. Results were analyzed with respect to karyotype, age, body mass index (BMI), and autoimmune indices. Insulin sensitivity and secretion were compared in age- and BMI-matched euglycemic women with TS and healthy female controls. We compared gene expression profiles in lymphocytes from differentially affected TS groups. Results: Type 2 DM was present in 56 of 224 (25%) of the women with TS; type 1 DM was found in only one woman (vs. 17.3%; P = 0.004). Euglycemic women with TS (n = 72; age, 33 ± 12 yr; BMI, 23 ± 3 kg/m2) had significantly higher glycemic and lower insulin responses to OGTT, with insulin sensitivity similar to controls. Gene expression profiles comparing 46,X,i(X)q vs. 45,X groups showed a significant increase in Xq transcripts and in potentially diabetogenic autosomal transcripts in the isoXq group. Conclusion: Type 2 DM associated with deficient insulin release is significantly increased among women with monosomy for the X-chromosome but is increased even more among women with monosomy for Xp coupled with trisomy for Xq. These data suggest that haploinsufficiency for unknown Xp genes increases risk for DM and that excess dosage of Xq genes compounds the risk. In Turner syndrome, haploinsufficiency for unknown Xp chromosome genes increases the risk for diabetes, and excess dosage of Xq genes compounds that risk.
- 1 November 2007
- Published by Elsevier in The Journal of Pediatrics
- Vol. 151 (5) , 528-531.e1
Uterine Development in Turner Syndrome
- 1 November 2007
- Published by Elsevier in The Journal of Pediatrics
- Vol. 151 (5) , 528-531.e1
Uterine Development in Turner Syndrome
- Open Access
- 26 October 2004
- Published by Springer Nature in BMC Women's Health
- Vol. 4 (1) , 8
Screening for known mutations in EIF2Bgenes in a large panel of patients with premature ovarian failure
Background: Premature Ovarian Failure (POF), defined as the development of hypergonadotropic amenorrhea before the age of 40 years, occurs in about 1% of all women. Other than karyotype abnormalities, very few genes are known to be associated with this ovarian dysfunction. Recently, in seven patients who presented with POF and white matter abnormalities on MRI (ovarioleukodystrophy) eight mutationswere found in EIF2B2, 4 and 5. Methods: To further test the involvement of known mutations of EIF2B genes in POF, we screened 93 patients with POF who did not have identified leukodystrophy or neurological symptoms. We evaluated these eight mutations and two additional mutations that had been found in patients with milder forms of eIF2B-related disorders. We used restriction enzymes and direct sequencing. Results: None of the known mutations in EIF2B genes, either homozygous or heterozygous, were identified in our 93 patients with pure 46,XX POF. The upper 95 % confidence limit of the proportion 0/93 is 3.2%. Conclusions: We conclude that eIF2B mutations, already described in cases of POF associated with white matter abnormalities, are an uncommon cause of pure spontaneous premature ovarian failure.
- 26 October 2004
- Published by Springer Nature in BMC Women's Health
- Vol. 4 (1) , 8
Open AccessScreening for known mutations in EIF2Bgenes in a large panel of patients with premature ovarian failure
Background: Premature Ovarian Failure (POF), defined as the development of hypergonadotropic amenorrhea before the age of 40 years, occurs in about 1% of all women. Other than karyotype abnormalities, very few genes are known to be associated with this ovarian dysfunction. Recently, in seven patients who presented with POF and white matter abnormalities on MRI (ovarioleukodystrophy) eight mutationswere found in EIF2B2, 4 and 5. Methods: To further test the involvement of known mutations of EIF2B genes in POF, we screened 93 patients with POF who did not have identified leukodystrophy or neurological symptoms. We evaluated these eight mutations and two additional mutations that had been found in patients with milder forms of eIF2B-related disorders. We used restriction enzymes and direct sequencing. Results: None of the known mutations in EIF2B genes, either homozygous or heterozygous, were identified in our 93 patients with pure 46,XX POF. The upper 95 % confidence limit of the proportion 0/93 is 3.2%. Conclusions: We conclude that eIF2B mutations, already described in cases of POF associated with white matter abnormalities, are an uncommon cause of pure spontaneous premature ovarian failure.
- 1 October 2004
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 89 (10) , 4886-4889
Growth Hormone Therapy and Bone Mineral Density in Turner Syndrome
In a previous report, preliminary data showed a significant reduction in cortical bone mineral density (BMD) in women with Turner syndrome that had been treated with GH compared with women with Turner syndrome that had not been treated. To clarify this point, we have investigated the effects of GH treatment at multiple sites in this case-control, cross-sectional study. There were 23 women per group, who were similar in age, height, body mass index, estrogen use, and ethnic makeup. Median age (range) at start and duration of GH treatment was 9 (3-17) and 5 (2-9) yr, respectively. GH-treated women had a slightly greater ( approximately 8%, P = 0.03) width of the radial shaft, but otherwise there were no significant differences between groups in bone dimensions or BMD at the distal radius, lumbar spine, or femoral neck. Furthermore, regression analysis in a linear model including independent variables of age, age at diagnosis, body mass index, presence of spontaneous puberty, and GH use confirmed that GH use did not contribute to variation in BMD.
- 1 October 2004
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 89 (10) , 4886-4889
Growth Hormone Therapy and Bone Mineral Density in Turner Syndrome
In a previous report, preliminary data showed a significant reduction in cortical bone mineral density (BMD) in women with Turner syndrome that had been treated with GH compared with women with Turner syndrome that had not been treated. To clarify this point, we have investigated the effects of GH treatment at multiple sites in this case-control, cross-sectional study. There were 23 women per group, who were similar in age, height, body mass index, estrogen use, and ethnic makeup. Median age (range) at start and duration of GH treatment was 9 (3-17) and 5 (2-9) yr, respectively. GH-treated women had a slightly greater ( approximately 8%, P = 0.03) width of the radial shaft, but otherwise there were no significant differences between groups in bone dimensions or BMD at the distal radius, lumbar spine, or femoral neck. Furthermore, regression analysis in a linear model including independent variables of age, age at diagnosis, body mass index, presence of spontaneous puberty, and GH use confirmed that GH use did not contribute to variation in BMD.
- 1 December 2003
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 88 (12) , 5717-5722
Selective Reduction in Cortical Bone Mineral Density in Turner Syndrome Independent of Ovarian Hormone Deficiency
Women with Turner syndrome (TS) are at risk for osteoporosis from ovarian failure and possibly from haploinsufficiency for bone-related X-chromosome genes. To establish whether cortical or trabecular bone is predominantly affected, and to control for the ovarian failure, we studied forearm bone mineral density (BMD) in 41 women with TS ages 18-45 yr and in 35 age-matched women with karyotypically normal premature ovarian failure (POF). We measured BMD at the 1/3 distal radius (D-Rad(1/3); predominantly cortical bone) and at the ultradistal radius (UD-Rad; predominantly trabecular bone) by dual x-ray absorptiometry. Women with TS had lower cortical BMD compared with POF (D-Rad(1/3) Z-score = -1.5 +/- 0.8 for TS and 0.08 +/- 0.7 for POF; P < 0.0001). In contrast, the primarily trabecular UD-Rad BMD was normal in TS and not significantly different from POF (Z-score = -0.62 +/- 1.1 for TS and -0.34 +/- 1.0 for POF; P = 0.26). The difference in cortical BMD remained after adjustment for height, age of puberty, lifetime estrogen exposure, and serum 25-hydroxyvitamin D (P = 0.0013). Cortical BMD was independent of serum IGF-I and -II, PTH, and testosterone in TS. We conclude that there is a selective deficiency in forearm cortical bone in TS that appears independent of ovarian hormone exposure and is probably related to X-chromosome gene(s) haploinsufficiency.
- 1 December 2003
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 88 (12) , 5717-5722
Selective Reduction in Cortical Bone Mineral Density in Turner Syndrome Independent of Ovarian Hormone Deficiency
Women with Turner syndrome (TS) are at risk for osteoporosis from ovarian failure and possibly from haploinsufficiency for bone-related X-chromosome genes. To establish whether cortical or trabecular bone is predominantly affected, and to control for the ovarian failure, we studied forearm bone mineral density (BMD) in 41 women with TS ages 18-45 yr and in 35 age-matched women with karyotypically normal premature ovarian failure (POF). We measured BMD at the 1/3 distal radius (D-Rad(1/3); predominantly cortical bone) and at the ultradistal radius (UD-Rad; predominantly trabecular bone) by dual x-ray absorptiometry. Women with TS had lower cortical BMD compared with POF (D-Rad(1/3) Z-score = -1.5 +/- 0.8 for TS and 0.08 +/- 0.7 for POF; P < 0.0001). In contrast, the primarily trabecular UD-Rad BMD was normal in TS and not significantly different from POF (Z-score = -0.62 +/- 1.1 for TS and -0.34 +/- 1.0 for POF; P = 0.26). The difference in cortical BMD remained after adjustment for height, age of puberty, lifetime estrogen exposure, and serum 25-hydroxyvitamin D (P = 0.0013). Cortical BMD was independent of serum IGF-I and -II, PTH, and testosterone in TS. We conclude that there is a selective deficiency in forearm cortical bone in TS that appears independent of ovarian hormone exposure and is probably related to X-chromosome gene(s) haploinsufficiency.
- Open Access
- 1 May 2003
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 18 (5) , 1133
Adrenal antibiotics detect asymptomatic auto-immune adrenal insufficiency in young women with premature ovarian failure
- 1 May 2003
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 18 (5) , 1133
Open AccessAdrenal antibiotics detect asymptomatic auto-immune adrenal insufficiency in young women with premature ovarian failure